|
Baseline
|
Follow - up
|
---|
N
|
73
|
73
|
Age (y)
|
40.8 ± 10.8
| |
Body weight (kg)
|
60.0 ± 13.9
|
63.1 ± 15.0***
|
Waist (cm)
|
84.1 ± 12.5
|
91.3***
|
BMI (kg/m2)
|
25.9 ± 5.5
|
27.2***
|
Percentage fat mass (%)
|
35.2 ± 5.4
|
36.7 ± 5.1**
|
Fat mass kg
|
23.1 ± 8.1
|
23.7 ± 8.0**
|
P-glucose (mmol/L)
|
4.12 ± 0.45
|
5.01 ± 1.25***
|
Insulin (pmol/L)
|
80.9 ± 42.6
|
83.4 ± 62.9
|
HOMA -IR
|
15.2 ± 9.1
|
19.0 ± 15.5**
|
Interleukin-6 (pg/mL)
|
2.03 ± 2.49
|
1.89 ± 1.50
|
TNF-α(pg/mL)
|
4.43 ± 5.98
|
3.35 ± 3.85**
|
- All values are means ± SD. HOMA-IR = homeostasis model of assessment ratio. TNF-α = tumor necrosis factor alpha. Significant differences during the follow-up period are represented by < 0.05*, < 0.01** and < 0.001*** (Wilcoxon signed rank test).